{"id":269,"date":"2019-09-06T15:48:20","date_gmt":"2019-09-06T19:48:20","guid":{"rendered":"https:\/\/www.businesslitigationtrends.com\/?p=269"},"modified":"2022-11-29T16:59:23","modified_gmt":"2022-11-29T21:59:23","slug":"legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence","status":"publish","type":"post","link":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/","title":{"rendered":"Legal Intelligencer: &#8216;T.M. v. Janssen Pharmaceuticals&#8217;\u2014Lessons on Standards of Evidence"},"content":{"rendered":"<p>In the September 5, 2019 edition of\u00a0<a href=\"http:\/\/law.com\/thelegalintelligencer\"><em>The Legal Intelligencer<\/em><\/a>, Edward T. Kang, Managing Member of Kang Haggerty wrote &#8220;&#8216;<a href=\"https:\/\/www.law.com\/thelegalintelligencer\/2019\/09\/05\/t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/\">T.M. v. Janssen Pharmaceuticals&#8217; &#8211; Lessons on Standards of Evidence<\/a>.&#8221;<\/p>\n<h4 class=\"article-description\"><em>The value of the reinstatement of T.M. v. Janssen for lawyers is that it clarifies laws about evidence, how courts determine evidence\u2019s reliability, and general lessons on procedural law.<\/em><\/h4>\n<p>Last month, the Pennsylvania Superior Court reinstated a case concerning the drug Risperdal, which had initially been dismissed mid-trial in 2016. Johnson &amp; Johnson subsidiary Janssen Pharmaceutical\u2019s drug, Risperdal, is currently the subject of thousands of suits alleging that the drug directly caused gynecomastia in many young men.<\/p>\n<div class=\"read_more_link\"><a href=\"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/\"  title=\"Continue Reading Legal Intelligencer: &#8216;T.M. v. Janssen Pharmaceuticals&#8217;\u2014Lessons on Standards of Evidence\" class=\"more-link\">Continue reading \u203a<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>In the September 5, 2019 edition of\u00a0The Legal Intelligencer, Edward T. Kang, Managing Member of Kang Haggerty wrote &#8220;&#8216;T.M. v. Janssen Pharmaceuticals&#8217; &#8211; Lessons on Standards of Evidence.&#8221; The value of the reinstatement of T.M. v. Janssen for lawyers is that it clarifies laws about evidence, how courts determine evidence\u2019s reliability, and general lessons on [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":170,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[480,414],"tags":[336,327],"coauthors":[535],"class_list":["post-269","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business-litigation-and-dispute-resolution","category-publications","tag-legal-intelligencer","tag-pennsylvania","publication_lawyer-edward-t-kang"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Legal Intelligencer: &#039;T.M. v. Janssen Pharmaceuticals&#039;\u2014Lessons on Standards of Evidence &#8212; Kang Haggerty News &#8212; September 6, 2019<\/title>\n<meta name=\"description\" content=\"In the September 5, 2019 edition of\u00a0The Legal Intelligencer, Edward T. Kang, Managing Member of Kang Haggerty wrote &quot;&#039;T.M. v. Janssen Pharmaceuticals&#039; - &#8212; September 6, 2019\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Legal Intelligencer: &#039;T.M. v. Janssen Pharmaceuticals&#039;\u2014Lessons on Standards of Evidence &#8212; Kang Haggerty News &#8212; September 6, 2019\" \/>\n<meta property=\"og:description\" content=\"In the September 5, 2019 edition of\u00a0The Legal Intelligencer, Edward T. Kang, Managing Member of Kang Haggerty wrote &quot;&#039;T.M. v. Janssen Pharmaceuticals&#039; - &#8212; September 6, 2019\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/\" \/>\n<meta property=\"og:site_name\" content=\"Kang Haggerty News\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-06T19:48:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-11-29T21:59:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.khflaw.com\/news\/wp-content\/uploads\/2017\/10\/KHFSocial.png\" \/>\n\t<meta property=\"og:image:width\" content=\"250\" \/>\n\t<meta property=\"og:image:height\" content=\"250\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Edward T. Kang\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Edward T. Kang\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Legal Intelligencer: 'T.M. v. Janssen Pharmaceuticals'\u2014Lessons on Standards of Evidence &#8212; Kang Haggerty News &#8212; September 6, 2019","description":"In the September 5, 2019 edition of\u00a0The Legal Intelligencer, Edward T. Kang, Managing Member of Kang Haggerty wrote \"'T.M. v. Janssen Pharmaceuticals' - &#8212; September 6, 2019","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/","og_locale":"en_US","og_type":"article","og_title":"Legal Intelligencer: 'T.M. v. Janssen Pharmaceuticals'\u2014Lessons on Standards of Evidence &#8212; Kang Haggerty News &#8212; September 6, 2019","og_description":"In the September 5, 2019 edition of\u00a0The Legal Intelligencer, Edward T. Kang, Managing Member of Kang Haggerty wrote \"'T.M. v. Janssen Pharmaceuticals' - &#8212; September 6, 2019","og_url":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/","og_site_name":"Kang Haggerty News","article_published_time":"2019-09-06T19:48:20+00:00","article_modified_time":"2022-11-29T21:59:23+00:00","og_image":[{"width":250,"height":250,"url":"https:\/\/www.khflaw.com\/news\/wp-content\/uploads\/2017\/10\/KHFSocial.png","type":"image\/png"}],"author":"Edward T. Kang","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Edward T. Kang","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/#article","isPartOf":{"@id":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/"},"author":{"name":"Edward T. Kang","@id":"https:\/\/www.khflaw.com\/news\/#\/schema\/person\/715d97d788a57e99416dcc912bc92bcf"},"headline":"Legal Intelligencer: &#8216;T.M. v. Janssen Pharmaceuticals&#8217;\u2014Lessons on Standards of Evidence","datePublished":"2019-09-06T19:48:20+00:00","dateModified":"2022-11-29T21:59:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/"},"wordCount":1583,"image":{"@id":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/#primaryimage"},"thumbnailUrl":"","keywords":["Legal Intelligencer","Pennsylvania"],"articleSection":["Business Litigation and Dispute Resolution","Publications"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/","url":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/","name":"Legal Intelligencer: 'T.M. v. Janssen Pharmaceuticals'\u2014Lessons on Standards of Evidence &#8212; Kang Haggerty News &#8212; September 6, 2019","isPartOf":{"@id":"https:\/\/www.khflaw.com\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/#primaryimage"},"image":{"@id":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/#primaryimage"},"thumbnailUrl":"","datePublished":"2019-09-06T19:48:20+00:00","dateModified":"2022-11-29T21:59:23+00:00","author":{"@id":"https:\/\/www.khflaw.com\/news\/#\/schema\/person\/715d97d788a57e99416dcc912bc92bcf"},"description":"In the September 5, 2019 edition of\u00a0The Legal Intelligencer, Edward T. Kang, Managing Member of Kang Haggerty wrote \"'T.M. v. Janssen Pharmaceuticals' - &#8212; September 6, 2019","breadcrumb":{"@id":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/www.khflaw.com\/news\/legal-intelligencer-t-m-v-janssen-pharmaceuticals-lessons-on-standards-of-evidence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"News","item":"https:\/\/www.khflaw.com\/news\/"},{"@type":"ListItem","position":2,"name":"Legal Intelligencer: &#8216;T.M. v. Janssen Pharmaceuticals&#8217;\u2014Lessons on Standards of Evidence"}]},{"@type":"WebSite","@id":"https:\/\/www.khflaw.com\/news\/#website","url":"https:\/\/www.khflaw.com\/news\/","name":"Kang Haggerty News","description":"Published By Kang Haggerty LLC","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.khflaw.com\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.khflaw.com\/news\/#\/schema\/person\/715d97d788a57e99416dcc912bc92bcf","name":"Edward T. Kang","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/8dcff756ae0093f937b15b5df94416a7c3d96219078d2839a5bc5728ba16357a?s=96&d=mm&r=ge0d0c7487856dd0dfc77d3733787f0e1","url":"https:\/\/secure.gravatar.com\/avatar\/8dcff756ae0093f937b15b5df94416a7c3d96219078d2839a5bc5728ba16357a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8dcff756ae0093f937b15b5df94416a7c3d96219078d2839a5bc5728ba16357a?s=96&d=mm&r=g","caption":"Edward T. Kang"},"sameAs":["https:\/\/www.khflaw.com\/"]}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.khflaw.com\/news\/wp-json\/wp\/v2\/posts\/269","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.khflaw.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.khflaw.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.khflaw.com\/news\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.khflaw.com\/news\/wp-json\/wp\/v2\/comments?post=269"}],"version-history":[{"count":3,"href":"https:\/\/www.khflaw.com\/news\/wp-json\/wp\/v2\/posts\/269\/revisions"}],"predecessor-version":[{"id":6419,"href":"https:\/\/www.khflaw.com\/news\/wp-json\/wp\/v2\/posts\/269\/revisions\/6419"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.khflaw.com\/news\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.khflaw.com\/news\/wp-json\/wp\/v2\/media?parent=269"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.khflaw.com\/news\/wp-json\/wp\/v2\/categories?post=269"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.khflaw.com\/news\/wp-json\/wp\/v2\/tags?post=269"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.khflaw.com\/news\/wp-json\/wp\/v2\/coauthors?post=269"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}